Peroxisome proliferator-activated receptor agonists modulate neuropathic pain: A link to chemokines?

Caroline M. Freitag, Richard J. Miller

Research output: Contribution to journalReview articlepeer-review

43 Scopus citations


Chronic pain presents a widespread and intractable medical problem. While numerous pharmaceuticals are used to treat chronic pain, drugs that are safe for extended use and highly effective at treating the most severe pain do not yet exist. Chronic pain resulting from nervous system injury (neuropathic pain) is common in conditions ranging from multiple sclerosis to HIV-1 infection to type II diabetes. Inflammation caused by neuropathy is believed to contribute to the generation and maintenance of neuropathic pain. Chemokines are key inflammatory mediators, several of which (MCP-1, RANTES, MIP-1α, fractalkine, SDF-1 among others) have been linked to chronic, neuropathic pain in both human conditions and animal models. The important roles chemokines play in inflammation and pain make them an attractive therapeutic target. Peroxisome proliferator-activated receptors (PPARs) are a family of nuclear receptors known for their roles in metabolism. Recent research has revealed that PPARs also play a role in inflammatory gene repression. PPAR agonists have wide-ranging effects including inhibition of chemokine expression and pain behavior reduction in animal models. Experimental evidence suggests a connection between the pain ameliorating effects of PPAR agonists and suppression of inflammatory gene expression, including chemokines. In early clinical research, one PPARα agonist, palmitoylethanolamide (PEA), shows promise in relieving chronic pain. If this link can be better established, PPAR agonists may represent a new drug therapy for neuropathic pain.

Original languageEnglish (US)
Article number238
JournalFrontiers in Cellular Neuroscience
Issue numberAUG
StatePublished - Aug 20 2014


  • Fractalkine
  • MCP-1
  • MIP-1α
  • Neuropathic pain
  • Peroxisome proliferator-activated receptors
  • SDF-1

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience


Dive into the research topics of 'Peroxisome proliferator-activated receptor agonists modulate neuropathic pain: A link to chemokines?'. Together they form a unique fingerprint.

Cite this